25 results on '"Blazing, Michael"'
Search Results
2. Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT
3. Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations
4. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
5. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)
6. Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status
7. Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)
8. Serial Measurement of Monocyte Chemoattractant Protein-1 After Acute Coronary Syndromes: Results From the A to Z Trial
9. The incidence and functional consequences of RT-associated cardiac perfusion defects
10. The association between depression and chronic kidney disease and mortality among patients hospitalized with congestive heart failure
11. Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia
12. Symptomatic Cardiac Events Following Radiation Therapy for Left-Sided Breast Cancer: Possible Association with Radiation Therapy—Induced Changes in Regional Perfusion
13. Atherosclerotic disease in non–insulin-dependent diabetes mellitus: Role of abnormal lipids and the place for lipid-altering therapies
14. THE HEALTH CARE BURDEN OF UNSTABLE ANGINA
15. SENTINEL EVENTS PRIOR TO SUDDEN CARDIAC DEATH AMONG CLINICALLY STABLE ACUTE CORONARY SYNDROME PATIENTS: INSIGHTS FROM THE IMPROVE-IT TRIAL
16. ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT
17. EVALUATION OF MEDICATION PERSISTENCE IN THE IMPROVE-IT TRIAL
18. LONG TERM SIGNIFICANCE OF HEART FAILURE COMPLICATING ACUTE MYOCARDIAL INFARCTION IN 11,185 PATIENTS FROM THE IMPROVED REDUCTION OF OUTCOMES: VYTORIN EFFICACY INTERNATIONAL TRIAL (IMPROVE-IT)
19. THE ASSOCIATION OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL WITH LONG-TERM ADVERSE EVENTS AMONG PATIENTS WITH ESTABLISHED CORONARY ARTERY DISEASE: INSIGHTS FROM THE IMPROVE-IT TRIAL
20. Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)
21. Evaluation of the National Cholesterol Education Program Adult Treatment Panel III Algorithm for Selecting Candidates for Statin Therapy: Insights from the A to Z Trial
22. An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design
23. 1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia
24. 861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial
25. Adenoviral gene transfer to venous bypass grafts and native vessels: A quantitative study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.